BPC 157: Prohibited peptide and unapproved drug in supplements The Food and Drug Administration will hold a meeting this summer to consider easing restrictions on more than a half dozen peptide injections, a group of unapproved therapies that have become popular The peptide problem: Hype is outrunning the evidence The peptide problem: Hype is outrunning the evidence Unauthorized injectable peptide drugs seized and sold by Canada Peptide may pose serious health risks Canada.ca Regulatory Alert: The Legal Status of BPC 157 in Compounding and Clinical Practice Holt Law